相关实验视频
Updated: May 28, 2025

12:24
Murine Model of CD40-activation of B cells
Published on: March 5, 2010
12.6K
双功能菌素粒子增强CD40激活和增强淋巴结向的提供个性化新抗原疫苗
Xiaotong Chen1,2, Lei Lei1,2, Jiayao Yan1,2
1The Comprehensive Cancer Centre of Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing 210008, China.
ACS nano
|February 11, 2025
概括
用抗CD40 DARPins (M13CD40) 进行工程设计的M13菌体有效地将个性化的新抗原癌症疫苗传递给淋巴结. 这种方法增强了免疫反应和抗瘤疗效,提供了一个有前途的癌症治疗策略.
科学领域:
- 生物技术和纳米医学
- 免疫学和癌症治疗疗法
背景情况:
- 个性化新抗原癌症疫苗显示出希望,但通过免疫刺激辅助剂有效地传递给淋巴结 (LNs) 仍然是一个挑战.
- M13菌体是多功能生物材料,由于其免疫性和生产效率,适合用于疫苗输送.
研究的目的:
- 开发一种双功能M13菌体平台,用于针对性地将新抗原疫苗输送到淋巴结.
- 为了研究M13菌体 (M13CD40) 上显示的抗CD40设计的基林重复蛋白 (DARPin) 的有效性,用于增强癌症免疫疗法.
主要方法:
- 设计的M13菌体显示抗CD40DARPins (M13CD40) 以针对性地传递给淋巴结中的CD40阳性细胞.
- 在临床前模型中评估了基于M13CD40的新抗原疫苗的LN积累,抗原保留,免疫反应和抗瘤疗效.
- 评估了与PD-1阻断的联合治疗.
主要成果:
- 与非向菌体相比,M13CD40在LNs中表现出增强的积累和长时间的抗原保留.
- 基于M13CD40的疫苗诱导了更强大的抗原特异性免疫反应和更高的抗瘤疗效,特别是在免疫性较差的瘤中.
- 与PD-1阻断的联合治疗进一步改善了瘤控制和T细胞细胞毒性.
结论:
- M13CD40作为一种有效的CD40纳米激动剂,也是个性化新抗原癌症疫苗淋巴结输送的向输送工具.
- 这种基于菌体的平台显示出改善癌症疫苗疗效和克服瘤诱导的免疫抑制的巨大潜力.
相关概念视频
Immune Response Against Viral Pathogens
731
The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
731
B Cell Activation and Differentiation
1.6K
The adaptive immune response, a sophisticated defense mechanism, relies on the activation and differentiation of B lymphocytes, or B cells. These processes enable our bodies to mount a tailored response against specific pathogens such as bacteria, free virus particles, toxins, and parasites.
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
1.6K
T Cell Activation and Clonal Selection
633
T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
Naive T cells that have not yet encountered an antigen express two primary CD...
633
Tumor Immunotherapy
464
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
464
Cytotoxic T Cells-mediated Immune Response
832
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
832
Cancer Vaccines
329
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
329

